# Neuramis® Volume Lidocaine Treatment in Patients With Loss of Mid-face Volume

> **NCT02721368** · NA · COMPLETED · sponsor: **Medy-Tox** · enrollment: 88 (actual)

## Conditions studied

- Aging

## Interventions

- **DEVICE:** Neuramis® Volume Lidocaine
- **DEVICE:** Juvederm® Voluma® with Lidocaine

## Key facts

- **NCT ID:** NCT02721368
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-03
- **Primary completion:** 2017-10-31
- **Final completion:** 2019-09-11
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02721368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02721368, "Neuramis® Volume Lidocaine Treatment in Patients With Loss of Mid-face Volume". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02721368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*